Various factors contribute to disparities in 30-day readmission rates following allogeneic hematopoietic stem cell transplantation (allo-HCT) among patients with acute myeloid leukemia (AML), ...

Rusfertide could be a new treatment option for patients with polycythemia vera, according to Andrew Kuykendall, MD.

BSO not associated with increased risk for cardiovascular diseases, ischemic heart disease, or cerebrovascular disease.

Using the COMPASS model, researchers project risk of cardiac late effects for survivors of pediatric ALL at age 50 years.

A postdevelopment study showed patients with gastric cancer were generally satisfied with the design and functionality of an intelligent individualized nutrition management applet.

Researchers sought to determine whether the ALL-Hematotox would be able to predict hematotoxicity for patients with B-ALL who are at risk of severe hematotoxicity following CAR-T therapy.